← Back to Search

Behavioral Intervention

Adapted Stress Management Program for Lung Cancer (SCAN Trial)

N/A

Recruiting

Led By Heather Derry-Vick, PhD

Research Sponsored by Hackensack Meridian Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 2

Adult (ages 18 and older)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-week pre-scan, 1-week post-scan, and 1-month follow-up

Awards & highlights

SCAN Trial Summary

This trial is studying a stress management program for people with cancer who are having regular cancer scans. The study will have two phases of testing. The first phase will test the program and make any necessary changes

Who is the study for?

This trial is for lung cancer patients awaiting scan results. Participants should be willing to undergo a stress management program or receive enhanced usual care. Specific eligibility details are not provided, but typically include factors like age, health status, and prior treatments.Check my eligibility

What is being tested?

The study tests a new stress management intervention against enhanced usual care in two phases: an initial Open Trial with 10 people to refine the program, followed by a Pilot Randomized Controlled Trial with 50 people to assess feasibility.See study design

What are the potential side effects?

Since this is a behavioral trial focusing on stress management techniques rather than medication or medical procedures, side effects are minimal and may include discomfort from discussing personal experiences or feelings during sessions.

SCAN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can take care of myself and am up and about more than half of my waking hours.

Select...

I am 18 years old or older.

Select...

My lung cancer is at stage IV or is extensive stage small cell.

SCAN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-week pre-scan, 1-week post-scan, and 1-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-week pre-scan, 1-week post-scan, and 1-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-week pre-scan, 1-week post-scan, and 1-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability - Perceived helpfulness

Acceptability - Usability

Acceptability of Intervention - Overall

+2 more

Secondary outcome measures

Anxiety

Cancer-related intrusive thoughts

Intervention engagement - Daily stress management skill practice

SCAN Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Adapted Stress Management ProgramExperimental Treatment1 Intervention

The behavioral intervention consists of 3 brief coaching sessions delivered by a trained research interventionist (at baseline/orientation, pre-scan, and post-scan time points) and program modules consisting of psychoeducation and stress management skill activities/practice. They will also be provided with a list of mental health resources and crisis line information for use if needed.

Group II: Enhanced Usual CareActive Control1 Intervention

Those randomized to enhanced usual care in the pilot RCT (n=25) will receive a resource list, tablet for study assessments, and reminder calls, but will not receive the program modules. They will also be provided with a list of mental health resources and crisis line information for use if needed.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,683 Previous Clinical Trials

40,928,733 Total Patients Enrolled

Hackensack Meridian HealthLead Sponsor

131 Previous Clinical Trials

28,167 Total Patients Enrolled

Heather Derry-Vick, PhDPrincipal InvestigatorHackensack Meridian Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively enroll participants in this trial?

"As per the current information available on clinicaltrials.gov, this trial is not actively seeking participants. The study was initially posted on January 10th, 2024 and last updated on December 29th, 2023. However, it's worth noting that there are currently 1568 other ongoing clinical trials that are recruiting patients at this time."

Answered by AI

Recent research and studies

Journal of Palliative MedicineJournal

Associations Between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results Among Advanced Cancer Patients

Derry, Heather M., Paul K. Maciejewski, Andrew S. Epstein, Manish A. Shah, Thomas W. LeBlanc, Valerie Reyna, and Holly G. Prigerson. 2019. “Associations Between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results Among Advanced Cancer Patients”. Journal of Palliative Medicine. Mary Ann Liebert Inc. doi:10.1089/jpm.2018.0624.

Implementation ScienceJournal

Psychometric Assessment of Three Newly Developed Implementation Outcome Measures

Weiner, Bryan J., Cara C. Lewis, Cameo Stanick, Byron J. Powell, Caitlin N. Dorsey, Alecia S. Clary, Marcella H. Boynton, and Heather Halko. 2017. “Psychometric Assessment of Three Newly Developed Implementation Outcome Measures”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-017-0635-3.

clinicaltrials.govStudy

Support for Cancer Patients Awaiting News

2024. "Support for Cancer Patients Awaiting News". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06199570.